Publication

When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines: A retrospective analysis of determinants of impact of safety warnings

Reber, K. C., Piening, S., Wieringa, J. E., Straus, S. M. J. M., Raine, J. M., de Graeff, P., Haaijer-Ruskamp, F. M. & Mol, P. G. M., Apr-2013, In : Clinical Pharmacology & Therapeutics. 93, 4, p. 360-365 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Reber_2013_Clin_Pharmacol_Ther.pdf

    Final publisher's version, 470 KB, PDF document

    Request copy

DOI

Serious safety issues relating to drugs are communicated to health-care professionals via Direct Health-Care Professional Communications (DHPCs). We explored which characteristics determined the impact of DHPCs issued in the Netherlands for ambulatory-care drugs (2001-2008). With multiple linear regression, we examined the impact on the relative change in new drug use post-DHPC of the following: time to DHPC, trend in use, degree of innovation, specialist drug, first/repeated DHPC, DHPC template, and type of safety issue. DHPCs have less impact on use of specialist drugs than nonspecialist drugs (P <0.05).The DHPCs' impact increased after availability of a template emphasizing the main problem (P <0.05), and for safety issues with a risk of death and/or disability (both P <0.05) (adjusted R-2 = 0.392). Risk communication can be effective, specifically in case of well-structured information, and very serious safety issues. Effectiveness may improve by tailoring DHPCs and adding other communication channels, for example for drugs that are increasingly being used.

Original languageEnglish
Pages (from-to)360-365
Number of pages6
JournalClinical Pharmacology & Therapeutics
Volume93
Issue number4
Publication statusPublished - Apr-2013

    Keywords

  • ADVERSE DRUG-REACTIONS, REGULATORY ACTION, EUROPEAN-UNION, SAFETY, WARNINGS, NETHERLANDS, SPECIALISTS

ID: 2264937